<DOC>
	<DOC>NCT01251848</DOC>
	<brief_summary>The study is to assess if sitaxsentan and ritonavir will affect the blood levels of each other when coadministered.</brief_summary>
	<brief_title>Drug Interaction Between Ritonavir And Sitaxsentan</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Ritonavir</mesh_term>
	<mesh_term>Sitaxsentan</mesh_term>
	<criteria>Healthy male subjects and/or women of nonchild bearing potential. Subjects (because of teratogenic risk of sitaxsentan) between the ages of 21 and 55 years, inclusive. Signed informed consent. Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease. History of significant alcohol and drug use. Has hepatic dysfunction.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Sitaxentan</keyword>
	<keyword>ritonavir</keyword>
	<keyword>drug interaction</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>